BACKGROUND: Hypertension prevention and control are among the most important public health priorities. We evaluated the impacts of a workplace intervention project "Stop Hypertension in Mobarakeh Steel Company" (SHIMSCO) on controlling hypertension in industrial workers.
Introduction
Cardiovascular diseases (CVDs) are a major cause of mortality and morbidity in Iran. 1 Although the overall prevalence of hypertension in Iran is 17.8%, the rate increases to 23% and 50% in 30-55 and > 55-year-old population, respectively. 2 However, the complication is less common in rural areas than urban areas. 3 On the other hand, low detection rates, high treatment drop-out, and poor compliance with medications have led to increased prevalence of uncontrolled hypertension and its complications in the recent years. 4 Physicians seem to be unable to control more than 30% of the total hypertensive population in their private offices. 5 Therefore, alternative medical care approaches such as workplace interventions have been suggested. 6, 7 Several studies designed to evaluate population-based approaches have showed unclear results. 8, 9 In a meta-analysis by Lim et al. health promotion was not found to be significantly beneficial in developed countries. 10 In contrast, in developing countries such as Mauritius and India, successful models have been designed and used in health promotion activities. [11] [12] [13] [14] Easy access to big proportions of population, ability to repeat the interventions in workplaces, and cost-effectiveness of these models are among their success reasons. Considering the high prevalence of hypertension and poor control in our country (Iran), 15 the "Stop Hypertension in Mobarakeh Steel Company" (SHIMSCO) study was conducted to evaluate the impacts of the "Workplace Intervention Project", 16 as one of the interventional projects of the "Isfahan Healthy Heart Program" (IHHP), 17 on hypertension management and control among employees and workers in the biggest industry in Isfahan, Iran.
Materials and Methods
IHHP, a community-based study, was conducted with the aim of CVD prevention and health promotion. 17, 18 The current study was a part of the "Workplace Intervention Project" which in turn has been one of ten interventional projects of IHHP carried out in "Mobarakeh Steel Company" with more than 14000 employees and workers in Isfahan. Totally, 7286 male employees and workers participated in the annual medical exam performed by the company. After examinations, 959 (13%) persons with systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) was ≥ 90 mmHg, or those who were using antihypertensive medications were invited to participate in this study by workplace follow up Unit. Blood pressure (BP) was re-assessed in these subjects to confirm their hypertension and 500 subjects (6.9%) were defined as confirmed hypertensives. 19 All hypertensives underwent routine lab tests and physical exams in the workplace follow up center. During 2008 to 2009, the participants and their spouses were referred to Isfahan Cardiovascular Research Institute (ICRI), a WHO (World Heart Organization) collaborating center), for more evaluation. However, only 293 individuals took part in the ICRI educational sessions while the rest participated in workplace clinics where the ICRI team delivered them the same educational program.
Demographic data including age, employment duration, educational level, and marital status was collected from all participants. They also completed a questionnaire regarding lifestyle behaviors such as unhealthy nutrition, physical inactivity and smoking. Height and weight were measured by Seca scales with light clothes and no shoes on. Body mass index (BMI) was then calculated as weight (kg) divided by height squared (m 2 ). Subjects with BMI ≥ 25 kg/m 2 were considered as overweight and obese. Patients were treated based on available hypertension treatment guidelines. The follow-up intervals were determined depending on the status of BP and associated risk factors in each patient individually. All study subjects received an educational program for management, treatment and control of hypertension. The program consisted of three educational interactive 4-hour sessions. The educational content included reducing salt and fat intake, adhering to diet for stopping hypertension (DASH) recommendations, 20 increasing physical activity and having regular aerobic exercise, smoking cessation of any type of tobacco products, decreasing daily calorie intake to reduce weight. It also covered information on the role of stresses in hypertension and how to cope with stress, risk factors for hypertension, recommendations for accurate BP measurements at home, advice to control other risk factors such as obesity and overweight, diabetes and lipid disorders, following and measuring BP at determined intervals in the follow-up clinic, the importance of adherence to treatment, medication side effects and evaluating the need for changes in drug regimens. All educations were delivered by trained physicians, nurses and dietitians and sometimes physical activity experts. A booklet including most of the educational content was provided to all participants. The patients were referred to cardiologists for further evaluations when needed. The whole baseline studies were repeated for each participant after finishing the educational sessions. The Ethics Committee of ICRI approved the study. In addition, all participants signed informed consents after they were explained about the aims and protocol of the study.
Data analysis
Data was analyzed in SPSS15. Paired t-test was used to compare mean values of SBP and DBP before and after the study in each group. Generalized estimating equations (GEE) were used to model correlated and longitudinal data for investigating the predictors of longitudinal changes in BP after controlling the confounding factors. The medication effect was assessed by ordinary linear regression (OLR). P values less than 0.05 were considered as significant.
Results
During 2008 to 2010, out of 7286 workers and employees who underwent the annual evaluation by the factory, 500 (6.9%) subjects with confirmed hypertension were included in our study. The demographic data of all participants is presented in table 1. Most subjects aged 45-54 years and 36.6% had 6-20 years of employment history. In addition, more than 78.0% had 12-16 years of education. The comparisons of SBP and DBP before and after the intervention program along with changes in associated risk factors are presented in table 2. After the intervention, a significant reduction in SBP (-7.97 ± 14.72 mmHg), DBP (-2.66 ± 9.96 mmHg) and mean arterial BP (-4.43 ± 10.60 mmHg) were seen (P < 0.001). However, SBP decreased less than DBP (Figure 1 ). After adjusting for confounding variables like age, education level, work shift, and BMI, GEE showed that SBP and DBP decreased about 0.115 and 0.054 mmHg/per month, respectively (Table 3 ). According to OLR on the other hand, SBP and DBP decreased about 4.88 and 2.57 mmHg upon adding each antihypertensive drug in the study. figure 2 shows the changes of SBP and DBP during the follow-up period. Figure 2 . Systolic and diastolic blood pressure changes during the study
Discussion
We found interventions in workplaces to be effective in reducing both SBP and DBP, especially SBP, among employees and workers. A previous study reported no significant differences in clinical outcomes between hypertensive patients receiving care at workplace from occupational health physicians, patients receiving programmed instructions about hypertension control and adherence, and those receiving a combination of both strategies. 21 We used a combination of pharmacological and non-pharmacological recommendations in our educational content. Many studies showed that worksites are appropriate places in which a huge population can be educated about healthrelated behaviors like overweight and obesity. 22 Therefore, in some countries, competitive and consecutive models have been designed and used in controlling hypertension in worksites. 21 Like our study, Chen et al. evaluated two previous workplace intervention programs in the Capital Steel Iron Company and Beijing Fangshan Community in China. They indicated that the rates of treatment and control of BP in hypertensive participants in the intervention sites were 98.1% and 72.0%, compared with 51.8% and 37.5% in the control sites, respectively. 23 Similar to our program, two other multidisciplinary intervention programs, involving provision of care at the worksite, special pill containers, counseling, reminders, self-monitoring, support groups, feedback and reinforcement reported positive effects on both adherence and clinical outcomes in patients with hypertension. 24, 25 It seems that having higher educational levels can improve the efficiency of intervention and also drug compliance. Our study population had a high educational level since 78% of them had secondary school education or more.
Our interventions decreased DBP significantly which is different from other studies. However, consistent with IHHP as a whole, we observed significant reductions in other risk factors such as serum triglyceride and cholesterol levels, while BMI did not change among our participants. The reduction in BP might have been caused by the intensive educational interventions or improvement of nonpharmacological treatment and patients' compliance to pharmacological treatment by the assistance of well-trained health professionals. The results of GEE showed the reductions in SBP and DBP to increase over time. OLR also revealed reductions by adding each antihypertensive medication (Table 3) . In other words, hypertension was better controlled in patients who took part in our program and were followed for a longer time. Furthermore, adding more drug components could lead to more desirable control, a finding that may support the recent concept of using several components in one pill to increase the compliance of hypertension patients.
Some studies suggested gender-related differences in BP reduction levels. Wu et al. reported an average decrease in SBP by 0.8 mmHg and 4 mmHg respectively for men and women following a workplace intervention program. However, DBP remained the same as baseline for both sexes. 26 This finding was not supported by other studies and our study cannot confirm it since we only evaluated male workers and employees. Furthermore, our study showed significant reductions in both SBP and DBP. In contrast, our previous reports showed significant decreases only in SBP while DBP remained constant after implementing the Workplace Project of IHHP in factories and offices in Isfahan and Najaf Abad. 16 Several reasons including differences in the dose, type and duration of the interventions, improper design to evaluate the benefits, frequency of follow-up, multidisciplinary approach and a declining trend of hypertension during the intervention period have been attributed to these equivocal results. [27] [28] [29] Furthermore, less change in DBP than SBP observed in most lifestyle intervention studies can probably be explained by the amount of salt consumption, lack of regular exercise, smoking, and having a family history of hypertension. 27 We faced fewer problems with lack of exercise as the majority of positions in Mobarakeh Steel Company are non-sedentary.
Both SBP and DBP reductions were observed until the end of the first year (Figure 2 ). During the second year however, less change in SBP and an increase in DBP were detected. Less patient compliance and follow-up after the first year seem to be important factors related to these changes. An active reminder system may thus be effective.
Conclusion
SHIMSCO, a Three-year interventional project in workplaces, was effective in reducing SBP and DBP among hypertensive employees and workers. The annual screening of the workers combined with proper management and control by health professionals and appropriate self-care by patients as well as regular worksite follow-up scan would lead to having better control over BP. The project can be applied as a model for management and prevention of other chronic diseases and hence health improvement in large industries.
